Canada markets closed

XOMA Corporation (XOMA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
24.05+0.71 (+3.04%)
At close: 04:00PM EDT
24.05 0.00 (0.00%)
After hours: 04:03PM EDT

XOMA Corporation

2200 Powell Street
Suite 310
Emeryville, CA 94608
United States
510 204 7200
https://www.xoma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Mr. Owen P. Hughes Jr.CEO & Director193.75kN/A1975
Mr. Thomas M. BurnsSenior VP of Finance & CFO759.24kN/A1974
Mr. Brad SitkoChief Investment Officer867.08kN/A1981
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Corporate Governance

XOMA Corporation’s ISS Governance QualityScore as of March 1, 2024 is 4. The pillar scores are Audit: 7; Board: 3; Shareholder Rights: 2; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.